TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide despite the availability of diverse treatment strategies. Much research progress has been made regarding immunotherapy but the effects remain unsatisfactory, highlighting the urgent need for novel immune-rel...
Main Authors: | Jiawei Rao, Xukun Wu, Xiaozhuan Zhou, Ronghai Deng, Yi Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.575776/full |
Similar Items
-
Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma
by: Xu D, et al.
Published: (2020-08-01) -
Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma
by: Wen-Jie Wang, et al.
Published: (2020-02-01) -
Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM: A Prognostic Biomarker for Metastasis
by: David Entenberg, et al.
Published: (2020-03-01) -
Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients
by: Feng Fang, et al.
Published: (2018-12-01) -
Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
by: Ze-Bing Song, et al.
Published: (2021-10-01)